Comparative efficacy and safety analysis of CSE-1034: An open labeled phase III study in community acquired pneumonia

Manu Chaudhary; Shiekh G. Ayub; Mohd A. Mir

doi:10.1016/j.jiph.2018.04.006

Comparative efficacy and safety analysis of CSE-1034: An open labeled phase III study in community acquired pneumonia

Journal of Infection and Public Health ◽

10.1016/j.jiph.2018.04.006 ◽

2018 ◽

Vol 11 (5) ◽

pp. 691-697

Author(s):

Manu Chaudhary ◽

Shiekh G. Ayub ◽

Mohd A. Mir

Keyword(s):

Safety Analysis ◽

Community Acquired Pneumonia ◽

Phase Iii ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Phase Iii Study

Download Full-text

Abstract P6-17-17: Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)

10.1158/1538-7445.sabcs18-p6-17-17 ◽

2019 ◽

Cited By ~ 1

Author(s):

Z Shao ◽

D Pang ◽

H Yang ◽

W Li ◽

S Wang ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Safety Analysis ◽

Phase Iii ◽

Efficacy And Safety ◽

Her2 Positive ◽

Asian Patients ◽

Phase Iii Study

Download Full-text

CSE-1034 versus ceftriaxone: Efficacy and safety analysis from a randomized, open-labeled phase III study in complicated urinary tract infections

Journal of Global Infectious Diseases ◽

10.4103/jgid.jgid_98_17 ◽

2018 ◽

Vol 10 (4) ◽

pp. 188 ◽

Cited By ~ 3

Author(s):

MohdAmin Mir ◽

Manu Chaudhary ◽

ShiekhGazalla Ayub

Keyword(s):

Urinary Tract ◽

Urinary Tract Infections ◽

Safety Analysis ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Study ◽

Tract Infections

Download Full-text

THU0140 Efficacy and Safety Analysis by Overall anti-Drug Antibody Results Up To Week 30 in Patients with Rheumatoid Arthritis Treated with Sb2 (An Infliximab Biosimilar) or Infliximab Reference Product in Phase III Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3359 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 232.1-232 ◽

Cited By ~ 2

Author(s):

J.-Y. Choe ◽

J.S. Smolen ◽

E. Keystone ◽

M.C. Genovese ◽

J. Choi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Reference Product ◽

Safety Analysis ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Study

Download Full-text

Homeopathic remedies to prevent and treat children acute respiratory viral infections: a comparative efficacy and safety analysis

SOVREMENNAYA PEDIATRIYA ◽

10.15574/sp.2015.71.71 ◽

2015 ◽

Vol 71 (7) ◽

pp. 71-75

Author(s):

S.O. Mokiya-Serbina ◽

◽

V.V. Chechel ◽

N.I. Zabolotnyaya ◽

◽

...

Keyword(s):

Viral Infections ◽

Safety Analysis ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Respiratory Viral Infections ◽

Homeopathic Remedies

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Stage Iiib ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A Phase III Study to Evaluate the Efficacy and Safety of APL-2 in Patients With PNH

Case Medical Research ◽

10.31525/ct1-nct04085601 ◽

2019 ◽

Author(s):

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Case Medical Research ◽

10.31525/ct1-nct04063163 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Extensive Stage

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718340215.793493941 ◽

2014 ◽

Author(s):

Kamran Ghoreschi ◽

Sebastian Volc

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Faculty Opinions recommendation of Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718874797.793499746 ◽

2014 ◽

Author(s):

Mark Levis

Keyword(s):

At Risk ◽

Uric Acid ◽

Tumor Lysis Syndrome ◽

Phase Iii ◽

Efficacy And Safety ◽

Tumor Lysis ◽

Plasma Uric Acid ◽

Multicenter Phase ◽

Phase Iii Study

Download Full-text

Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab‐refractory follicular lymphoma patients in the GADOLIN phase III study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13974 ◽

2019 ◽

Vol 85 (9) ◽

pp. 1935-1945 ◽

Cited By ~ 1

Author(s):

Ekaterina Gibiansky ◽

Leonid Gibiansky ◽

Vincent Buchheit ◽

Nicolas Frey ◽

Michael Brewster ◽

...

Keyword(s):

Follicular Lymphoma ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Study

Download Full-text